Faricimab Treat-and-Extend for Diabetic Macular Edema: Two-Year Results from the Randomized Phase 3 YOSEMITE and RHINE Trials

YOSEMITE and RHINE Investigators

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
JournalOphthalmology
DOIs
StateAccepted/In press - 2024

ASJC Scopus Subject Areas

  • Ophthalmology

Keywords

  • Angiopoietin-2
  • Diabetic macular edema
  • Faricimab
  • Vascular endothelial growth factor A
  • Vascular stability

Cite this